Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)

Next Previous
Trial Profile

Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Nov 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bazedoxifene (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms VIOLINE
  • Sponsors Pfizer

Most Recent Events

  • 22 Sep 2016 Status changed from active, no longer recruiting to completed.
  • 14 Mar 2016 Planned End Date changed from 1 Dec 2015 to 1 May 2016 as per ClinicalTrials.gov record.
  • 14 Mar 2016 Planned primary completion date changed from 1 Dec 2015 to 1 May 2016 as per ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top